As pharma R&D leaders bring together their discovery and early development organizations they face tough decisions. How do you optimize project planning across a seamless R&D process? What is the right balance between risk, cost and value in the face of uncertainty? When and how should you deploy predictive technologies such as biomarkers? This webinar [...]
Tessella are proudly sponsoring the 6th Annual Biomarkers Congress taking place on February 23-24th, 2011 in Manchester, UK. Tom Parke, Head of Clinical Technologies at Tessella will be speaking at the event. His talk will be on Incorporating Biomarkers into Trial Designs. To find out more or to register on-line visit http://www.biomarkers-congress.com
Tessella are platinum sponsors of Bio-IT World Conference and Exhibition 2011, taking place at the World Trade Centre in Boston, US on April 12-14, 2011. To find out more or to register online visit http://www.bio-itworldexpo.com/
CAMBRIDGE | OXFORD UK, July 8 2010 – Optibrium, a provider of software solutions for drug discovery, and Tessella, the technology and consulting services company, today published a new paper highlighting that scientists’ instincts may not always lead them to making good drug discovery decisions. The challenges of decision-making arise from the importance of multiple/conflicting [...]
By Andrew T. Chadwick and Matthew D. Segall Better individual and team decision-making should enhance R&D performance. Reproducible biases affecting human decision-making, known as cognitive biases, are well understood by psychologists. These threaten objectivity and balance and so are credible causes for continuing unpleasant surprises in Development and high operating costs…read more
In Feb 2010 the FDA issued a draft guidance for industry on “Adaptive Design Clinical Trials for Drugs and Biologics” (pdf). Join Tom Parke in this on-demand webinar as he quizzes adaptive trial gurus Prof Don Berry and Dr Scott Berry on the implications of the FDA Guidance. Tom will be getting answers to the key [...]
Register for our live webcast on Tuesday, 8 June 2010 08:00 (PDT) 11:00 (EDT) 16:00 (BST) 17:00 (CEST) Join Tom Parke as he quizzes adaptive trial gurus Prof. Don Berry and Dr. Scott Berry on the implications of the recent FDA Guidance on Adaptive Design for Clinical Trials. Tom will be getting answers to the key [...]
Tessella and Berry Consultants are pleased to announce that they will be exhibiting at the JMS 2010 event on July 31-August 5th 2010, Vancouver, BC, Canada. JSM is the largest gathering of statisticians held in North America, bringing together the members of the following statistical societies: American Statistical Association International Biometric Society Institute of Mathematical [...]
Tom Parke unveils prototype version of combination finder trial design software at CHI’s combination therapies conference. Oxford, UK | 14 April 2010. Today, Tessella, the information technology and consulting services company selected by R&D, science and engineering leaders for business-critical assignments previewed clinical trial design software that addresses the challenge of designing Phase 1 trials [...]
Tessella are Silver sponsors of the Design Optimization and Implementation for Adaptive Clinical Trials 2010, taking place on October 7-8th 2010, Jersey City, NJ, USA. With the recent FDA guidance released earlier this year, adaptive clinical trials are becoming a more attractive option to reach credible statistical decisions in a suitable amount of time. These [...]
